Treatment of Patients with Mild to Moderate Ulcerative Colitis: A Middle East Expert Consensus

被引：2

作者：

Al Awadhi, Sameer ^{[1
]}

Alboraie, Mohamed ^{[2
]}

Albaba, Emad Aldin ^{[3
]}

Almutairdi, Abdulelah ^{[4
]}

Alsaad, Monther ^{[5
]}

Azzam, Nahla ^{[6
]}

Barakat, Husam ^{[7
]}

D'Amico, Ferdinando ^{[8
,9
,10
]}

Danese, Silvio ^{[8
,9
]}

El Kady, Mohamed ^{[11
]}

Ghoneim, Hossam ^{[12
]}

Hamoudi, Waseem ^{[13
]}

Jazzar, Ahmad ^{[14
]}

Mosli, Mahmoud ^{[15
]}

Shehab, Hany ^{[16
]}

Sneineh, Awni Abu ^{[17
]}

机构：

[1] Rashid Hosp, Digest Dis Unit, Dubai 003206, U Arab Emirates

[2] Al Azhar Univ, Dept Internal Med, Cairo 11884, Egypt

[3] Almana Gen Hosp, Dept Med, Al Khobar 31952, Saudi Arabia

[4] King Faisal Specialist Hosp & Res Ctr, Dept Med, Riyadh 11564, Saudi Arabia

[5] Al Madar Med Ctr, POB 80789, Sharjah, U Arab Emirates

[6] King Saud Univ, Coll Med, Dept Med, Div Gastroenterol, Riyadh 11451, Saudi Arabia

[7] Yarmouk Univ, Dept Gastroenterol, Irbid 21163, Jordan

[8] IRCCS Osped San Raffaele, Gastroenterol & Endoscopy, I-20132 Milan, Italy

[9] Univ Vita Salute San Raffaele, I-20132 Milan, Italy

[10] Humanitas Univ, Dept Biomed Sci, I-20132 Milan, Italy

[11] Cairo Univ, Fac Med, Dept Med Pharmacol, Cairo 11559, Egypt

[12] Alexandria Univ, Med Res Inst, Immunol & Allergy Dept, Alexandria 5424041, Egypt

[13] Al Bashir Hosp, Internal Med Dept, Amman 11151, Jordan

[14] Sheikh Khalifa Med City, Gastroenterol Div, Abu Dhabi 51900, U Arab Emirates

[15] King Abdulaziz Univ Hosp, Dept Med, Jeddah 21589, Saudi Arabia

[16] Cairo Univ, Integrated Clin & Res Ctr Intestinal Disorders IC, Endem Med Dept, Gastroenterol Div, Cairo 3725121, Egypt

[17] Univ Jordan, Gastroenterol & Hepatol, Amman 11942, Jordan

来源：

JOURNAL OF CLINICAL MEDICINE | 2023年 / 12卷 / 21期

关键词：

5-ASA; mesalazine; budesonide MMX; ulcerative colitis; inflammatory bowel disease; RANDOMIZED CLINICAL-TRIAL; INFLAMMATORY-BOWEL-DISEASE; VS; 2.4; G/DAY; ORAL MESALAZINE; TOPICAL; 5-AMINOSALICYLATES; DOUBLE-BLIND; MAINTENANCE; REMISSION; EFFICACY; GUIDELINES;

D O I：

10.3390/jcm12216929

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The prevalence of ulcerative colitis (UC) in the Middle East is increasing, impacting the economic and healthcare burden. The management of patients with mild to moderate UC is still a challenge as several factors can affect optimal care, including drug choice, induction and maintenance dose, treatment optimization and de-escalation, therapy duration, monitoring, and safety profile. We conducted an expert consensus to standardize the management of patients with mild to moderate UC. Sixteen experts in inflammatory bowel diseases, through a well-established and accepted Delphi methodology, voted and approved eight statements in order to provide practical guidance to clinicians in the Middle East.

引用

页数：11

共 50 条

[21] The budgetary impact of 2 g mesalazine for the treatment of mild to moderate ulcerative colitis
Lovelace, I.
Tate, E.
Knapp, S.
Masure, J.
Shields, G.
JOURNAL OF CROHNS & COLITIS, 2014, 8 : S200 - S201
[22] Appropriateness of Treatment Options in Mild to Moderate Ulcerative Colitis: A RAND Appropriateness Panel
Irving, Peter M.
Melmed, Gil Y.
Lightner, Amy L.
Kotze, Paulo
Ullman, Thomas
Raffals, Laura E.
Baidoo, Leonard
Bressler, Brian
Cheifetz, Adam
Devlin, Shane
Jones, Jennifer
Kozuch, Patricia
Sparrow, Miles
Velayos, Fernando
Siegel, Corey A.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S479 - S480
[23] Modeling Endoscopic Improvement after Induction Treatment With Mesalamine in Patients With Mild-to-Moderate Ulcerative Colitis
Ma, Christopher
Jeyarajah, Jenny
Guizzetti, Leonardo
Parker, Claire E.
Singh, Siddharth
Dulai, Parambir S.
D'Haens, Geert R.
Sandborn, William J.
Feagan, Brian G.
Jairath, Vipul
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (02) : 447 - +
[24] Safety and tolerance of rHuIL-10 treatment in patients with mild/moderate active ulcerative colitis.
Schreiber, S
Fedorak, RN
Wild, G
Gangl, A
Targan, S
Jacyna, M
Wright, JP
Kilian, A
Cohard, M
Lebeaut, A
Tremaine, WJ
GASTROENTEROLOGY, 1998, 114 (04) : A1080 - A1081
[25] A novel combination of oral/enema treatment for induction of remission in patients with mild/moderate distal Ulcerative Colitis
Wruble, Lawrence
Pravda, Jay
INFLAMMATORY BOWEL DISEASES, 2011, 17 : S50 - S50
[26] Mild to moderate ulcerative colitis: sequential and combined treatments
Coelho, J.
Marteau, P.
INTESTINAL DISORDERS, 2009, 164 : 103 - 106
[27] Design of Clinical Trials for Mild to Moderate Ulcerative Colitis
Sedano, Rocio
Jairath, Vipul
Ma, Christopher
GASTROENTEROLOGY, 2022, 162 (04) : 1005 - 1018
[28] Budesonide MMX®: A Review of Its Use in Patients with Mild to Moderate Ulcerative Colitis
Hoy, Sheridan M.
DRUGS, 2015, 75 (08) : 879 - 886
[29] Recommendations for the optimal use of mesalazine in the management of patients with mild to moderate ulcerative colitis
Akbar, Ayesha
Arnott, Ian
Kennedy, Nicholas A.
Nolan, Jonathan
Peake, Simon
Whiteoak, Simon R.
Probert, Chris
Fraser, Aileen
Cheshire, Alex
Lewis, Allyson
Sugrue, Kathleen
Laird, Susan
Scott, Glyn
BRITISH JOURNAL OF HOSPITAL MEDICINE, 2021, 82 (10)
[30] Budesonide MMX®: A Review of Its Use in Patients with Mild to Moderate Ulcerative Colitis
Sheridan M. Hoy
Drugs, 2015, 75 : 879 - 886

← 1 2 3 4 5 →